Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01943474 · ClinicalTrials.gov registry record · NA
AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
NCT01943474: Completed NA study, sponsored by C. R. Bard.
NCT01943474 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 248 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01943474, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
Study Summary
The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (IV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to conventional IV catheters.
Primary Outcome
The primary outcomes measure is to observe first attempt success rate in patients requiring peripheral IV access by documenting the number of catheter attempts (each new catheter) required to complete successful peripheral IV placement.
Interventions
- DEVICE AccuCath IV Catheter Device
- DEVICE Conventional IV Catheter Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-10 |
| Phase | NA |
What the finished NCT01943474 record still lists
NCT01943474 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which AccuCath IV Catheter Device is the first listed.
NCT01943474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01943474 about?
NCT01943474 is a clinical study titled "AccuCath Guidewire Intravenous (IV) Device Versus Conventional IV Catheter In General Nursing Use". The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (IV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to conventional IV catheters.
What is the current status of trial NCT01943474?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2013-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01943474?
The interventions under investigation include: AccuCath IV Catheter Device (DEVICE), Conventional IV Catheter Device (DEVICE).
Who is sponsoring clinical trial NCT01943474?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01943474's enrollment target sits among peer trials
248 434th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia